The Campaign for Sustainable Rx Pricing, of which the AHA is a founding member, today released a digital and television ad urging Congress to pass the Creating and Restoring Equal Access to Equivalent Samples Act to lower drug prices. The ad is running on CNN and Fox in Washington, DC, and on Facebook and Twitter. The CREATES Act (S. 974/H.R. 2212) would allow generic drug manufacturers facing certain anticompetitive delay tactics to bring an action in federal court for injunctive relief. More than 40 organizations, including the AHA, last month urged House and Senate leaders to pass the legislation. 

Related News Articles

Perspective
Last week, I shared a few areas where we can advance health in America this year, even in a divided Congress.
Headline
Continued rising drug prices, as well as shortages for many critical medications, are disrupting patient care and forcing hospitals to delay infrastructure and…
Perspective
We’re 11 days into 2019 … we’ve returned to a divided government …and the partial government shutdown continues.
Insights and Analysis
Also in this weekly roundup of health news: AHA president and CEO Rick Pollack speaks to HealthLeaders about the association’s year ahead; digital health…
Headline
As Congress prioritizes action to lower drug prices, the Campaign for Sustainable Rx Pricing yesterday announced a website to help lawmakers and their staff…
Headline
AHA commends the Centers for Medicare…